Skip to main content

Table 1 Antibiotic resistance of Esherichia coli strains isolated from Libyan children during 2001 & 2007

From: Fecal carriage of extended-spectrum β-lactamases and AmpC-producing Escherichia coli in a Libyan community

Antibiotic

2001

2007

P-values*

Total

(N = 85)

(N = 49)

(N = 134)

Ampicillin

69 (81.2)**

36 (73.5)

0.3

105 (78.4)

Ampicillin/Sulbactam

50 (58.8)

26 (53.1)

0.5

76 (56.7)

Amoxicillin/Clavulanic

54 (63.5)

32 (65.3)

0.8

86(64.2)

Imipenem

0

0

N/A

0 (0.0)

Cephalothin

67 (78.8)

30 (61.2)

0.03

97 (72.4)

Cefotaxime

23 (27.1)

4 (8.2)

0.009

27 (20.2)

Ceftriaxone

22 (25.9)

4 (8.2)

0.01

26 (19.4)

Ceftazidime

23 (27.1)

4 (8.2)

0.009

27 (20.2)

Chloramphenicol

39 (45.9)

8 (16.3)

0.0005

47(35.1)

Nalidixic acid

4 (4.7)

9 (18.4)

0.01

13 (9.7)

Ciprofloxacin

2 (2.4)

5 (62.5)

<0.0001

7 (5.2)

Streptomycin

57 (67.1)

28 (57.1)

0.2

85 (63.4)

Trimethoprim/sulfamethoxazole

54 (63.5)

29 (59.2)

0.6

83 (61.9)

Tetracycline

48 (56.5)

22 (44.9)

0.2

70 (52.2)

  1. * Fisher’s exact test.
  2. **Data presented as N (%) of resistance cases, where N: Number of cases displaying resistance.
  3. N/A: Not applicable.